Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Operating Expenses | 2,034 | 1,131 | 1,398 | 1,519 | 1,221 |
| Operating Income | -2,034 | -1,131 | -1,398 | -1,519 | -732 |
| Other Income | -318 | 3 | 3 | 2 | 3 |
| Pre-tax Income | -2,352 | -1,128 | -1,394 | -1,517 | -729 |
| Net Income Continuous | -2,352 | -1,128 | -1,394 | -1,517 | -729 |
| Net Income | $-2,352 | $-1,128 | $-1,394 | $-1,517 | $-729 |
| EPS Basic Total Ops | -0.10 | -0.05 | -0.06 | -0.08 | -0.04 |
| EPS Basic Continuous Ops | -0.10 | -0.05 | -0.06 | -0.08 | -0.04 |
| EPS Diluted Total Ops | -0.10 | -0.05 | -0.06 | -0.08 | -0.04 |
| EPS Diluted Continuous Ops | -0.10 | -0.05 | -0.06 | -0.08 | -0.04 |
| EBITDA(a) | $-2,027 | $-1,124 | $-1,376 | $-1,513 | $-1,215 |